Peroxin 11γ Activators
Peroxin 11γ include a variety of compounds that engage with different regulatory mechanisms within the cell to initiate its activation. Bisphenol A, through its ability to bind to estrogen receptors, sets off a cascade of cellular signaling pathways that lead to changes in lipid metabolism and peroxisome proliferation, which in turn can activate Peroxin 11γ. Compounds such as clofibrate, bezafibrate, fenofibrate, and ciglitazone are known to activate peroxisome proliferator-activated receptors (PPARs), which directly upregulate the expression of genes involved in peroxisome proliferation, thereby promoting the activation of Peroxin 11γ. Each of these chemicals, although differing in structure, share a common mechanism of binding to PPARs, leading to transcriptional changes that enhance the biogenesis of peroxisomes and the subsequent activation of peroxisomal proteins.
In addition to the fibrates and PPAR agonists, other chemicals also play a role in the activation of Peroxin 11γ through their involvement in lipid signaling and metabolism. For instance, rosiglitazone and pioglitazone, both PPARγ agonists, stimulate the peroxisomal biogenesis pathways, indirectly contributing to the activation of Peroxin 11γ. Moreover, leukotriene B4 interacts with G-protein-coupled receptors, triggering signaling pathways that can culminate in the activation of peroxisomal enzymes, including Peroxin 11γ. Furthermore, mevalonic acid, oleic acid, docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA) influence the peroxisomal proliferation and activation of peroxisomal proteins through their roles in cellular lipid balance and signaling. These fatty acids and metabolites, by altering lipid metabolism, can lead to an upsurge in the peroxisome number and function, implicating the activation of Peroxin 11γ as part of this complex lipid homeostasis network.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
Bisphenol A can bind to estrogen receptors, which can have downstream effects on cellular signaling pathways, including the activation of peroxins such as Peroxin 11γ by influencing lipid metabolism and peroxisome proliferation. | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $33.00 | ||
As a fibrate, clofibrate can activate peroxisome proliferator-activated receptors (PPARs) which are known to regulate the expression of genes involved in peroxisome proliferation and function, thereby leading to the activation of Peroxin 11γ. | ||||||
Bezafibrate | 41859-67-0 | sc-204650B sc-204650 sc-204650A sc-204650C | 500 mg 1 g 5 g 10 g | $31.00 $46.00 $122.00 $204.00 | 5 | |
Bezafibrate acts as an agonist to PPARs leading to the induction of peroxisome proliferation and could result in the activation of peroxisomal proteins, including Peroxin 11γ. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Fenofibrate is a PPARα agonist, and by activating PPARα, it can contribute to the proliferation of peroxisomes and the consequent activation of associated peroxisomal proteins such as Peroxin 11γ. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone is a PPARγ agonist, which may lead to the indirect activation of peroxisomal proteins, including Peroxin 11γ, through the modulation of lipid metabolism and peroxisome biogenesis. | ||||||
LTB4 (Leukotriene B4) | 71160-24-2 | sc-201043 | 50 µg | $374.00 | 4 | |
Leukotriene B4 can activate certain G-protein-coupled receptors, which might initiate signaling cascades that result in the activation of peroxisomal enzymes and proteins, including Peroxin 11γ. | ||||||
Ciglitazone | 74772-77-3 | sc-200902 sc-200902A | 5 mg 25 mg | $104.00 $428.00 | 10 | |
Ciglitazone activates PPARγ, which can lead to the increased biogenesis of peroxisomes and the activation of peroxisomal proteins including Peroxin 11γ. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone is another PPARγ agonist which by its agonistic action can lead to the indirect activation of Peroxin 11γ as part of the peroxisome proliferation and lipid metabolism process. | ||||||
Oleic Acid | 112-80-1 | sc-200797C sc-200797 sc-200797A sc-200797B | 1 g 10 g 100 g 250 g | $37.00 $104.00 $580.00 $1196.00 | 10 | |
Oleic acid can induce peroxisome proliferation and thereby activate peroxisomal proteins, including Peroxin 11γ, by altering lipid metabolism and signaling through PPARs. | ||||||
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) | 6217-54-5 | sc-200768 sc-200768A sc-200768B sc-200768C sc-200768D | 100 mg 1 g 10 g 50 g 100 g | $94.00 $210.00 $1779.00 $8021.00 $16657.00 | 11 | |
DHA can enhance peroxisome proliferation and the activation of Peroxin 11γ through its role in lipid signaling and metabolism, potentially engaging PPARs. | ||||||